Picture of IXICO logo

IXI IXICO Income Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Annual income statement for IXICO, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
R2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue7.569.539.198.646.67
Cost of Revenue
Gross Profit4.946.356.025.243.27
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses7.28.688.077.748.1
Operating Profit0.3640.8561.120.908-1.44
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes0.3660.8581.10.885-1.36
Provision for Income Taxes
Net Income After Taxes0.4320.9521.511.03-1.18
Net Income Before Extraordinary Items
Net Income0.4320.9521.511.03-1.18
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income0.4320.9521.511.03-1.18
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.0090.020.030.021-0.024